Ac Immune Sa Asset Turnover Ratio (ACIU), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ac Immune Sa  (NASDAQ: ACIU)
 

Ac Immune Sa Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2025, Ac Immune Sa's asset turnover ratio sequentially decreased to 0.03 in the fourth quarter (Dec 31 2025), this is lower than usual.

Within sector 209 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 4174.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACIU Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Asset Change -17.16 % -33.2 % -33.37 % -33.2 % 31.18 %
Y / Y Revenue Change -86.92 % - 108.3 % - 84.51 %
Asset Turnover Ratio (TTM) 0.03 - 0.15 - 0.12
ACIU's Total Ranking # 4174 # 0 # # #
Seq. Asset Change 26.01 % 0 % 0 % -34.26 % 1.61 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 210
Healthcare Sector # 590
Overall Market # 4174

Asset Turnover Ratio Statistics
High Average Low
0.12 0.07 0.02
(Dec 31 2024)   (Dec 31 2025)




ACIU Company Profile • Back to ACIU Efficiency Comparisons • Compare ACIU Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Concord Medical Services Holdings Ltd  0.07 $ 65.852  Millions$ 936.260  Millions
Precigen Inc   0.07 $ 9.684  Millions$ 139.363  Millions
Safe Pro Group Inc   0.07 $ 0.607  Millions$ 9.009  Millions
Cytokinetics Incorporated  0.07 $ 88.039  Millions$ 1,337.695  Millions
Protagonist Therapeutics inc   0.07 $ 46.016  Millions$ 707.504  Millions
Nexalin Technology Inc   0.06 $ 0.302  Millions$ 4.806  Millions
Agape Atp Corporation  0.06 $ 1.524  Millions$ 24.722  Millions
Omniab Inc   0.06 $ 18.666  Millions$ 303.115  Millions
Vir Biotechnology Inc   0.06 $ 68.556  Millions$ 1,130.634  Millions
Alector Inc   0.06 $ 21.045  Millions$ 348.312  Millions
Entrada Therapeutics Inc   0.06 $ 25.421  Millions$ 431.385  Millions
Tonix Pharmaceuticals Holding Corp   0.06 $ 13.107  Millions$ 227.460  Millions
Abeona Therapeutics Inc   0.06 $ 11.376  Millions$ 199.066  Millions
Abcellera Biologics Inc   0.06 $ 75.128  Millions$ 1,364.803  Millions
Recursion Pharmaceuticals Inc   0.05 $ 74.681  Millions$ 1,370.311  Millions
Alumis inc   0.05 $ 24.050  Millions$ 443.044  Millions
Grail Inc   0.05 $ 147.172  Millions$ 2,768.301  Millions
Seer Inc   0.05 $ 16.465  Millions$ 318.610  Millions
Caribou Biosciences Inc   0.05 $ 11.159  Millions$ 216.228  Millions
Biorestorative Therapies Inc   0.05 $ 0.360  Millions$ 7.141  Millions
Inventiva S a   0.05 $ 13.898  Millions$ 279.452  Millions
Astrotech Corp  0.05 $ 1.199  Millions$ 24.354  Millions
Sinovac Biotech Ltd  0.05 $ 385.981  Millions$ 8,541.725  Millions
Can fite Biopharma Ltd   0.04 $ 0.405  Millions$ 9.066  Millions
Camp4 Therapeutics Corporation  0.04 $ 3.498  Millions$ 79.563  Millions
Viskase Holdings inc   0.04 $ 1.921  Millions$ 44.202  Millions
Aclaris Therapeutics Inc   0.04 $ 7.826  Millions$ 180.809  Millions
Kyntra Bio Inc   0.04 $ 6.440  Millions$ 149.969  Millions
Onkure Therapeutics Inc   0.04 $ 3.433  Millions$ 80.226  Millions
Valion Bio Inc   0.04 $ 0.482  Millions$ 11.530  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.